受强制性开放获取政策约束的文章 - Fernanda Marconi Roversi了解详情
可在其他位置公开访问的文章：13 篇
WNT5A in tumor development and progression: A comprehensive review
MLP Bueno, STO Saad, FM Roversi
Biomedicine & Pharmacotherapy 155, 113599, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia
FM Roversi, MLP Bueno, JAF da Silva, GR Assis-Mendonça, CO Torello, ...
Cancer Immunology, Immunotherapy 71 (8), 1909-1921, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
The antitumor effects of WNT5A against hematological malignancies
MLP Bueno, STO Saad, FM Roversi
Journal of cell communication and signaling 17 (4), 1487-1499, 2023
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
Combined Inhibition of MCL1 By AZD5991 and BCL2/Bclxl By AZD4320 As Promising Strategies to Overcome Acute Leukemia Tumor Burden and Niche Chemoresistance
MLP Bueno, L Artico, ASS Duarte, A Basso, JA Yunes, ST Olalla Saad, ...
Blood 140 (Supplement 1), 4943-4944, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
HGF Regulation in the Tumor-Supportive Microenvironment Combined with Pan-PIM Kinases Inhibition in Malignant Cells As a Multi-Target Approach for Acute Myeloid Leukemia
FM Roversi, MLP Bueno, FS Niemann, I Santos, NG Amôr, ...
Blood 142, 3641, 2023
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
Inhibition of MET Tyrosine Kinase Provides a Strategy for Targeting the Inflammatory Tumor Microenvironment
MLP Bueno, I Santos, NG Amôr, AD da Silva Santos, A Bastos, KP Ferro, ...
Blood 142, 2264, 2023
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
Optimized multiplex immunofluorescence for the characterization of tumor immune microenvironment in neoplastic paraffin-preserved tissues
FM Roversi, MLP Bueno, JAF da Silva, GR Assis-Mendonça, STO Saad
Journal of cell communication and signaling 17 (3), 1055-1065, 2023
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment
FM Roversi, MLP Bueno, A Basso, ASS Duarte, JAF Silva, ST Olalla Saad
Blood 140 (Supplement 1), 7806-7807, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
TARGETING PAN-PIM KINASES IN ACUTE MYELOID LEUKEMIA: A POTENTIAL THERAPEUTIC STRATEGY
MLP Bueno, STO Saad, FM Roversi
Hematology, Transfusion and Cell Therapy 44, S142, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
INIBIÇÃO DA PROTEÍNA HCK: UMA PROMISSORA ESTRATÉGIA PARA O TRATAMENTO DE LEUCEMIAS AGUDAS
FM Roversi, MLP Bueno, A Bastos, ADS Santos, JAF Silva, STO Saad
Hematology, Transfusion and Cell Therapy 44, S143-S144, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
INIBIDORES DE PROTEÍNAS DA FAMÍLIA BCL-2 CONTRA NEOPLASIAS HEMATOLÓGICAS E SEUS EFEITOS NA COMBINAÇÃO COM CITARABINA, VENETOCLAX E DOXORRUBICINA
MLP Bueno, LL Artico, ADS Santos, A Bastos, JA Yunes, STO Saad, ...
Hematology, Transfusion and Cell Therapy 44, S144-S145, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
TOCOTRIENOL NO TRATAMENTO DAS LEUCEMIAS AGUDAS: EFEITOS ANTINEOPLÁSICOS IN VITRO E IN VIVO
MLP Bueno, MA Foglio, STO Saad, FM Roversi
Hematology, Transfusion and Cell Therapy 44, S145, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
THE MCL-1 INHIBITOR AZD5991 DISPLAYS A PROMISING TARGETED THERAPY FOR ACUTE MYELOID LEUKEMIA
MLP Bueno, STO Saad, FM Roversi
Hematology, Transfusion and Cell Therapy 43, S180, 2021
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
出版信息和资助信息由计算机程序自动确定